Where the category stands in May 2026 — what's available, who to trust, what costs what. 22-min read, medically reviewed.
Read the guideAn independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.
View the provider overviewOverview & reviewsPrimers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.
View all Learn articlesWhat compounded and branded semaglutide and tirzepatide actually cost, from each provider's own published pricing.
Last updated: June 2026
PeptideWellness is an independent editorial publication covering peptide therapy, GLP-1 medications, and the providers that prescribe them. This policy sets out the standards we hold ourselves to — independence, accuracy, and how we handle the places where commerce and editorial judgment could collide. For the mechanics of sourcing and verification, see our methodology.
Peptide therapy is a field where the marketing has run years ahead of the evidence, and where the people searching for answers — about GLP-1 medications, recovery peptides, or where to get them safely — are making decisions that affect their health and their money. Most of what ranks for those searches is written by the companies selling the product or by content farms summarizing them. We exist to be the source that isn't: independent, sourced, and willing to say when something doesn't work or isn't worth the price. If a page reads like it's trying to sell you something, we've failed our own standard.
We do not accept payment from peptide manufacturers, compounding pharmacies, telehealth providers, or clinics in exchange for coverage, placement, or scoring. Provider coverage is determined by editorial judgment alone. We have no commercial relationship with any provider we cover.
If commercial revenue mechanisms launch in the future, they will be clearly labeled, kept separate from editorial pages, and never used as an input to how we rank, score, or describe a provider. The judgment that decides which provider we call good or bad, or which compound we call evidence-backed or research-only, stays independent of any commercial arrangement. When anything changes here, this page is the first place it gets noted. How we handle outbound links to providers is set out in our privacy policy.
If an editor or reviewer holds a financial interest in a company covered in a piece, that interest is disclosed in the piece. Where the interest is material to the editorial judgment, that person recuses from the piece entirely. As of this update, PeptideWellness has no commercial relationships with any provider, manufacturer, or compounding pharmacy it covers.
We correct factual mistakes. Material corrections carry a dated note on the affected page; smaller fixes update the "last reviewed" date. The fastest way to reach us about an error is [email protected]. Our full corrections process is described in our methodology.
Clinical content is reviewed by a licensed medical reviewer with relevant specialty training before it carries a medical-review byline. We don't list a reviewer on a page until that person has signed an editorial agreement and is verifiable; the review is a substantive fact-check against trial data and prescribing labels, not a courtesy signature. See our authors & medical review page for how this works.
Related reading: our methodology, authors & medical review, and team.
Editorial note: this page is for informational purposes and does not constitute medical advice. Always consult a licensed healthcare provider before beginning, changing, or stopping any peptide therapy or medication.